Skip to main content

Teleflex Inc(TFX-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low134.73
Day High137.75
Open:136.25
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
Analysts Offer Insights on Healthcare Companies: Teleflex (TFX) and MBX Biosciences, Inc. (MBX)
Motley Fool
Teleflex (TFX) Q4 2024 Earnings Transcript
Tipranks
Mizuho Securities Reaffirms Their Hold Rating on Teleflex (TFX)
Tipranks
Analysts Offer Insights on Healthcare Companies: Teleflex (TFX), Cigna (CI) and BioNTech SE (BNTX)
StockStory
A Look Back at Surgical Equipment & Consumables - Specialty Stocks’ Q4 Earnings: Teleflex (NYSE:TFX) Vs The Rest Of The Pack
TFX
StockStory
3 Unprofitable Stocks with Questionable Fundamentals
ASAN
Tipranks
Teleflex Reaffirms Strategy Amid Activist Pressure on Board
StockStory
Why Teleflex (TFX) Stock Is Up Today
TFX
StockStory
3 Small-Cap Stocks with Warning Signs
UTZ
Tipranks
Teleflex Clears Key Antitrust Hurdle for OEM Divestiture
Tipranks
Analysts Offer Insights on Healthcare Companies: Adicet Bio (ACET), Teleflex (TFX) and Medacta Group SA (OtherMEDGF)
StockStory
3 Reasons TFX is Risky and 1 Stock to Buy Instead
TFX
StockStory
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know
TECH
Tipranks
Truist Financial Remains a Hold on Teleflex (TFX)
Tipranks
Analysts Offer Insights on Healthcare Companies: Teleflex (TFX), Progyny (PGNY) and Wave Life Sciences (WVE)
Tipranks
Teleflex Earnings Call Maps Painful Reset, Future Upside
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Rhythm Pharmaceuticals (RYTM), Teleflex (TFX)
Tipranks
Teleflex Launches Multi-Year Restructuring to Support Divestitures
Motley Fool
Teleflex (TFX) Q4 2025 Earnings Call Transcript
StockStory
Teleflex (NYSE:TFX) Misses Q4 CY2025 Sales Expectations, Stock Drops
TFX
StockStory
Teleflex (TFX) Q4 Earnings: What To Expect
TFX
StockStory
1 of Wall Street’s Favorite Stock Worth Your Attention and 2 We Avoid
ANF
StockStory
3 Cash-Producing Stocks with Warning Signs
GME
Motley Fool
Teleflex Stock Slides 39% in a Year, but This $8.5 Million Buy Signals a Contrarian Bet
Motley Fool
Why One Fund Just Bet $4 Million on Teleflex Stock Despite a 42% One-Year Drop
Tipranks
Analysts Offer Insights on Healthcare Companies: Teleflex (TFX) and Compass Therapeutics (CMPX)
Tipranks
Teleflex completes CEO transition and separation agreement
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Teleflex (TFX) and Biogen (BIIB)
StockStory
3 Value Stocks We Think Twice About
FIVN
Tipranks
Teleflex (TFX) Gets a Hold from RBC Capital
Tipranks
Teleflex Announces CEO Transition Amid Strategic Portfolio Shift
GlobeNewswire
Teleflex Announces Leadership Transition

Profile

Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of direct sales force and distributors. Teleflex has manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.